Physician profile
Tricia Stytle
NPI 1871595090
$2,452.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,332 · 2020: $89.40 · 2021: $530 · 2022: $501.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $438.95 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $311.52 | 2019-2022 | |
| Amgen INC. | $296.14 | 2019-2021 | |
| Lilly USA, LLC | $293.20 | 2019-2022 | |
| Novo Nordisk INC | $224.74 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.76 | 2019-2022 | |
| Genzyme Corporation | $185.00 | 2019 | |
| Astellas Pharma US INC | $118.15 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $51.80 | 2021 | |
| Abbott Laboratories | $49.45 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $45.70 | 2019 | |
| Dexcom, INC. | $33.40 | 2021 | |
| Pfizer INC. | $30.89 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.93 | 2019 | |
| Glaxosmithkline, LLC. | $27.12 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.93 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.57 | 2019 | |
| Eisai INC. | $18.89 | 2021 | |
| Medtronic, INC. | $16.46 | 2022 | |
| Depuy Synthes Sales INC. | $13.68 | 2019 | |
| Abbvie INC. | $11.95 | 2022 | |
| Allergan, INC. | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Stytle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.